Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Identification of dysregulated gene clusters and pathways driving ocular surface squamous neoplasia progression
Kartik Goel1, Shruti Rathore1,2, Prisha Warikoo1
1Eicher-Shroff Centre for Stem Cell Research, Dr. Shroff's Charity Eye Hospital, Kedarnath Lane, Daryaganj, 5027, 110002, New Delhi, India.
Abstract:
Ocular Surface Squamous Neoplasia (OSSN) represents a spectrum of ocular malignancies that threaten vision and ocular integrity. To unravel the molecular mechanisms underlying OSSN progression, we conducted RNA-sequencing on conjunctival tissues from healthy individuals and patients with OSSN. Our analysis revealed marked alterations in the expression of genes implicated in inflammation, immune dysregulation, cell cycle regulation, and cellular stress responses. Notably, genes such as TP53, CXCL9, CXCL11, IL6, TNFα, MMP7, MMP9, GSTM1, IFNα, and IL1β showed significant dysregulation in OSSN samples compared to controls. Pathway enrichment analysis highlighted the activation of Interferon-α, Interferon-γ, and IL6/JAK-STAT3 signaling, alongside pathways regulating inflammatory response, p53 signaling, G2M checkpoint, and apical surface integrity. Together, these findings indicate that OSSN is characterized by a pro-inflammatory and proliferative transcriptomic profile driven by chronic immune signaling and disrupted cell cycle control. These findings provide novel insights into the transcriptional landscape of OSSN and identify key pathways that may be targeted for improved diagnosis and therapy. The molecular insights provided by this study can potentially inform stratified management approaches and aid in the development of novel treatments for this challenging ocular surface malignancy.
Insights
Ocular Surface Squamous Neoplasia (OSSN) involves significant gene expression changes in inflammation and cell cycle control. This study reveals a pro-inflammatory and proliferative profile in OSSN, offering targets for new therapies.
Area of Science:
- Ophthalmology
- Oncology
- Molecular Biology
Background:
- Ocular Surface Squamous Neoplasia (OSSN) is a group of eye cancers impacting vision.
- Understanding the molecular basis of OSSN progression is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the transcriptomic landscape of OSSN.
- To identify molecular mechanisms driving OSSN development and progression.
Main Methods:
- RNA-sequencing was performed on conjunctival tissues from OSSN patients and healthy controls.
- Gene expression alterations and pathway enrichment analyses were conducted.
Main Results:
- Significant dysregulation of genes involved in inflammation (e.g., IL6, TNFα, IL1β), immune response (e.g., CXCL9, CXCL11, IFNα), cell cycle (e.g., TP53), and stress responses were observed.
- Activated pathways included Interferon-α, Interferon-γ, IL6/JAK-STAT3 signaling, inflammatory response, p53 signaling, and G2M checkpoint.
- OSSN samples exhibited a pro-inflammatory and proliferative transcriptomic profile.
Conclusions:
- OSSN is characterized by chronic immune signaling and disrupted cell cycle control.
- These findings provide insights into OSSN's molecular drivers.
- Identified pathways may serve as therapeutic targets for OSSN management.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
07:37Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
Published on: August 16, 2024